MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric CancerTao Wang(Union Hospital), Yuping Yin(Union Hospital)Frontiers in OncologyApril 11, 202210.3389/fonc.2022.844135Cited by 9SaveCiteExport RISWatch citationsRelated PapersCombination of <scp>PARP</scp> inhibitor and <scp>CDK4</scp>/6 inhibitor modulates <scp>cGAS</scp>/<scp>STING‐</scp>dependent therapy‐induced senescence and provides “one‐two punch” opportunity with <scp>anti‐PD‐L1</scp> therapy in colorectal cancer|Cancer Science|2023|38Cell Cycle Regulation of DNA Polymerase Beta in Rotenone-Based Parkinson's Disease Models|PLoS ONE|2014|17